Skip to main content
. Author manuscript; available in PMC: 2008 Aug 20.
Published in final edited form as: J Cardiovasc Electrophysiol. 2006 Nov;17(11):1230–1238. doi: 10.1111/j.1540-8167.2006.00592.x

Table 3.

Multiple linear regression analysis of the atrial cell L-type Ca2+ current, ICaL. Post-CS period studied=3 days. ICaL estimate=estimated difference in mean ICaL between highest (eg: drug-treatment) and lowest (eg: non-drug-treatment) level of variable, or male minus female. Values are subject (patient) means±standard error (SE). Number of patients with post-CS AF=18/103.

Variable ICaL
estimate
(pA/pF)
ICaL
SEM
P
Post-CS AF −0.27 0.71 0.70
Male −0.37 0.63 0.56
Age (5 year increment) +0.14 0.14 0.35
Heart rate (10 bpm increment) −0.17 0.20 0.40
Pre-CS β-blocker −0.57 0.82 0.49
Post-CS β-blocker withdrawal +0.18 0.63 0.77
Pre-CS ACE inhibitor −0.30 0.54 0.58
Valve surgery +0.49 0.75 0.52
Hypertension +0.41 0.49 0.41
LVSD −0.23 0.53 0.67